Diagnostic and therapeutic procedures for management of melanoma during pregnancy: Risks for the fetus? Case report and review of the literature;Diagnostische und therapeutische maßnahmen in der behandlung des malignen melanoms während der schwangerschaft: Risiko für den fetus? Fallbericht und literatur-überblick

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 9, 2006, Pages 717-720

  Egberts, Friederike ^a   Lischner, Stephan ^a   Russo, Paul ^b   Kampen, W Uwe ^a   Hauschild, Axel ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Interferon; Malignant melanoma; Pregnancy; Sentinel node biopsy

Indexed keywords

ALPHA2B INTERFERON;

CANCER ADJUVANT THERAPY; CANCER MORTALITY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GENERAL ANESTHESIA; GESTATIONAL AGE; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; INFORMED CONSENT; LABOR INDUCTION; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; PREGNANCY; PREGNANCY OUTCOME; PREOPERATIVE EVALUATION; REVIEW; SENTINEL LYMPH NODE BIOPSY; TISSUE SECTION; TWIN PREGNANCY;

FEMALE; FETAL DISEASES; HUMANS; MELANOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; UTERINE NEOPLASMS;

EID: 33748484868     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.06055.x     Document Type: Review

References (14)

1. Thomas JM, Newton-Bishop J, A'Hern R, Coombes G, Timmons M, Evans J, Cook M, Theaker J, Fallowfield M, O'Neill T, Ruka W, Bliss JM. Excision margins in high-risk malignant melanoma. N Engl J Med 2004; 350: 757-766.
2. Morton DL, Wen DR, Wong JH, Economou JS, Cage LA, Storm FK, Foshag LJ, Cochran AJ. Technical details of intraoperative mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
3. Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross ML, Noyes RD, Viar V, Cerrito PB, McMasters KM. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003; 10: 676-680.
4. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alpha 2b adjuvant therapy of high-risk resected cutaneous melanoma. J Clin Oncol 1996; 14: 7-17.
5. Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, Newton Bishop JA: Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 2004; 22: 4369-4375.
6. Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ. Pregnancy and early stage melanoma. Cancer 2003; 97(9): 2248-2253.
7. Kusama T, Ota K. Radiological protection for diagnostic examination of pregnant women. Congenit Anom 2002; 42(1): 10.
8. Waddington WA, Keshtgar MR, Taylor I, Lakhani SR, Short MD, Ell PJ. Radiation safety for the sentinel lymph node technique in breast cancer. Eur J Nucl Med 2000; 27(4): 377-391.
9. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004; 15: 1348-1351.
10. Steenvoorde P, Pauwels EK, Harding LK, Bourguignon M, Mariere B, Broerse JJ. Diagnostic nuclear medicine and risk for the fetus. Eur J Nucl Med 1998; 25(2): 193-199.
11. Harding LK, Reiners D, Talbot J. Uterine radiation doses. Eur J Nucl Med 1994; 21: BP41.
12. Schott C, Schmidt H. General anesthesia in pregnancy. Anaesthesist 1998; 47: 525-536.
13. Trotter JF, Zygmunt AJ. Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C. J Clin Gastroenterol 2001; 32(1): 76-78.
14. st trimester: report of 3 cases and review of the literature. Am J Hematol 2002; 69: 115-118.